Please login to the form below

Not currently logged in
Email:
Password:

financial results

This page shows the latest financial results news and features for those working in and with pharma, biotech and healthcare.

Opdivo trial overshadows BMS financial results

Opdivo trial overshadows BMS financial results

Hope remains in Celgene merger. Bristol-Myers Squibb posted a 10% increase in revenues in the second quarter, but reporting focused on mixed results in a trial of its main growth ... patients” and would be discussing the results with regulators “as

Latest news

  • Vertex files cystic fibrosis triple therapy with FDA Vertex files cystic fibrosis triple therapy with FDA

    This forecast was boosted when its main challenger, Proteostatis Therapeutics, reported disappointing results for its rival triple therapy programme. ... CF.”. The company will report its second quarter 2019 financial results on Wednesday 31 July.

  • Hardy returns to Genentech as CEO Hardy returns to Genentech as CEO

    He also insisted that the decision is completely unrelated to its financial and business performance, with Q4 results expected to be announced on 5 February.

  • Credit Score Credit Score

    Failing to provide the necessary financial proof results in, very simply, a denial of your transplant. ... We tell ourselves that we are not using financial stability as a gateway to care, but we are.

  • Novo Nordisk’s Ozempic is quick out of the blocks, chasing Lilly’s Trulicity Novo Nordisk’s Ozempic is quick out of the blocks, chasing Lilly’s Trulicity

    Novo Nordisk is claiming a 14% share of the new-to-brand prescription market with Ozempic, and says “initial feedback from prescribers and payers is positive” in its first-half results ... Obesity drug dropped. In an R&D update accompanying the

  • The secret of success The secret of success

    How does this relate to the business models of life science companies and the current crop of financial results? ... Well, just as in the competition between species, we can see a distinct polarisation of results.

More from news
Approximately 70 fully matching, plus 113 partially matching documents found.

Latest Intelligence

  • Deal Watch - May 2017 Deal Watch - May 2017

    some financial companies to re-emerge as Barbarians.  The 2008 financial crash is a salutary reminder. ... What happens next?    Assuming the deal is completed, DW predicts the new Stada will start to hunt for product and company acquisitions to

  • Deal Watch August 2016 Deal Watch August 2016

    company rather than seeking a short term financial 'fix' to improve its financial results.”. ... In the same way that the asset acquisition deal between AstraZeneca and Pfizer had the financial structure of a licence, so too does the Pfizer acquisition

  • Technology: the missing link in true patient engagement? Technology: the missing link in true patient engagement?

    This comes at a huge financial cost, and results in suboptimal patient outcomes. ... While manual adherence programmes with assigned nurses have yielded positive outcomes, it isn't always possible to provide this widely due to financial and resource

  • Deal Watch April 2016 Deal Watch April 2016

    term financial 'fix' to improve its financial results. ... The deal with Nimbus did not excite investors and they were even less impressed when Gilead reported first quarter results showing sales growth of 4% and full year guidance of $30bn

  • Who tops the pharma list? Who tops the pharma list?

    Chris Ross, with the help of healthcare analysts GlobalData, takes a New Year look at the past, present and future of global pharma, and asks: what’s trending? 

More from intelligence
Approximately 1 fully matching, plus 4 partially matching documents found.

Latest appointments

  • BMS appoints Peter Arduini to board of directors BMS appoints Peter Arduini to board of directors

    Lamberto Andreotti, chairman of BMS, said: “Pete is a confident and engaging leader who has delivered tremendous results throughout his career. ... His commercial, financial and operational experience, along with a deep understanding of healthcare,

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Say Communications

Influencing positive behaviours and delivering change is what drives us, using thought leadership, education, social and professional engagement and compelling,...

Latest intelligence

Empowered patients: shaking the foundations of healthcare
Precision medicine represents a new paradigm in healthcare.This new approach to treating and preventing disease views the patient holistically, analysing their genes, environment and lifestyle, and using this information to...
A uniquely English genomic medicine service
The UK National Health Service is developing one standardised approach to embedding precision medicine across the whole of England. Blue Latitude Health speaks to Dr Tom Fowler, Deputy Chief Scientist...
Blended Intelligence
Data is the most valued commodity of the modern world. For P&P it's all about the application....

Infographics